1. Introduction
Osteoarthritis (OA) of the hip and knee is one of the most prevalent chronic musculoskeletal disorders, affecting over 500 million individuals globally. Its prevalence is increasing in Europe and worldwide, primarily due to aging populations, obesity, and joint injuries [
1,
2,
3]. Knee OA is the most common site and a leading contributor to years lived with disability, while hip OA also imposes a significant burden, with notable sex differences in prevalence across both conditions [
4]. Collectively, hip and knee OA are major contributors to reduced physical function, impaired quality of life, and rising healthcare costs, posing a central challenge to health systems [
5,
6]. Given the demographic shift towards aging societies and the projected substantial increase in osteoarthritis prevalence over the coming decades [
7,
8,
9], effectively addressing OA through prevention, early diagnosis, and evidence-based management strategies has become a pressing priority for clinical practice and public health.
Exercise and physical activity are fundamental evidence-based interventions for hip and knee OA, as substantiated by systematic reviews, meta-analyses, and international guidelines, which consistently demonstrate benefits in pain relief, functional improvement, and prognosis [
10,
11,
12,
13,
14]. Interventions ranging from aerobic and strength-training programs to mind-body approaches and aquatic exercise yield effects comparable to pharmacological therapies, while also enhancing quality of life and aiding in the management of comorbidities such as cardiovascular disease and diabetes [
12,
13,
15]. No single exercise modality has been proven superior, as all forms of regular activity appear to be beneficial, with moderate-intensity exercise performed 2-3 times weekly emerging as a pragmatic recommendation [
14,
16]. Exercise is generally safe for most patients with OA, with a minimal risk of serious adverse events [
11,
17]. Guidelines consistently advocate exercise, weight management, and self-management as first-line strategies [
7,
10]. However, despite this evidence and the central role of physical activity in OA management, implementation remains suboptimal. Contributing factors include patient barriers (such as pain, kinesiophobia, and low motivation), clinician factors (including outdated beliefs and limited confidence in prescribing exercise), and systemic issues (such as lack of access to programs and insufficient adherence support) [
18,
19,
20].
Standardized measurement tools are essential for assessing and improving the quality of OA care. The Osteoarthritis Quality Indicator (OA-QI) questionnaire provides structured, measurable items that translate guideline recommendations into auditable domains, such as assessment, education, exercise counseling, weight management, pharmacological management, and follow-up [
21,
22]. Developed through systematic reviews and expert consensus, often including patient involvement, OA-QI sets have demonstrated their validity and feasibility for use in both clinical audits and patient-reported surveys [
23,
24]. International adaptation across various countries consistently revealed the underuse of non-pharmacological strategies, particularly exercise and lifestyle counseling, highlighting their role in benchmarking and guiding quality improvement initiatives [
25].
Despite significant international advancements in the development of OA quality indicators, there is a deficiency in validated, regionally adapted instruments for South Tyrol and Italy. The bilingual (i.e. German and Italian) healthcare context of the region has constrained the capacity of general practice networks to systematically measure quality and to benchmark outcomes. The current initiative addresses this issue by translating the OA-QI questionnaire into German and Italian for application within South Tyrol's healthcare setting, thereby facilitating standardized patient-reported assessments of OA care [
26]. This adaptation ensures cultural relevance and enables cross-border comparisons with future data from Austria and other German speaking countries. Up until now, the broader Italian primary care landscape lacked such standardized tools, and reviews have indicated deficiencies in OA management practices [
27,
28]. On this line, the South Tyrol project will establish a foundation for quality monitoring while also supporting international benchmarking and testing the feasibility of integrating the South Tyrolean system. Feasibility testing is a critical methodological step when introducing standardized instruments into new cultural and health system contexts, as it ensures that questionnaires are both linguistically adapted and practically applicable before broader validation [
29,
30,
31]. Without this process, even well-validated instruments may fail to accurately capture the intended constructs, leading to invalid results [
32,
33]. Therefore, the present study evaluated the feasibility, acceptability, and test–retest reliability of the German and Italian versions of the OA-QI v3 questionnaire in general practice, while also providing an initial description of care gaps, particularly in patient education, exercise, and lifestyle counseling.
2. Methods
2.1. Study Design and Setting
This study was designed as a cross-sectional, practice-based survey within the South Tyrolean General Practice Research Network (SAMNET), a regional collaboration of general practitioners (GPs) engaged in health services research [
34].
The bilingual context of South Tyrol provided the opportunity to test both language versions while considering the cultural and organizational features of primary care in Italy. The
a priori targeted sample size was 280 patients, based on 40 GPs each enrolling seven consecutive eligible patients during routine consultation. This approach mirrored international OA-QI validation studies conducted in Norway [
23] and the Netherlands [
35], but was adapted to the South Tyrolean setting.
Sample size considerations were pragmatic and reflected the recruitment capacity of the network. For questionnaire validation, subject-to-item ratios of approximately 1:5 to 1:30 are considered sufficient [
36]. With 17 OA-QI items, the targeted sample size corresponded to a ratio of approximately 1:16. For test–retest reliability, a minimum of 50 participants is recommended [
37].
2.2. Participants
2.2.1. General Practitioners
Forty GPs affiliated with the SAMNET were invited to participate. Each physician was asked to recruit seven consecutive patients with hip or knee OA during routine consultations. To ensure methodological completeness, each practice contributed to the main survey and specific subgroups: one patient per practice was assigned to the comprehensibility assessment, and two patients were assigned to the test–retest reliability assessment. The GPs were responsible for informing the patients, obtaining written consent, and assigning anonymized study codes. The completed questionnaires were sealed by the patients in envelopes and returned in bulk to the study center.
2.2.2. Patients
Patients were eligible if they (i) had a known diagnosis of hip or knee OA or presented with knee or hip pain and fulfilled NICE-based clinical criteria (age ≥45 years, activity-related joint pain, and no or <30 minutes of morning stiffness) [
38], and (ii) were able to complete the questionnaire in German or Italian language. The exclusion criteria were as follows: malignant disease, rheumatoid or other inflammatory arthritis, Kellgren–Lawrence grade IV joint degeneration, other inflammatory rheumatic conditions, psychiatric or cognitive disorders preventing participation, and concurrent involvement in other clinical studies.
2.2.3. Recruitment Flow
Of the 40 invited GPs, 38 actively participated (95.0%). Together, they recruited 266 patients, corresponding to 95.0% of the planned sample size of 280. All patients completed the main OA QI questionnaire. In addition, 89 patients completed the retest questionnaire approximately 14 days later, and 40 patients completed the comprehensibility module.
2.3. Study Registration
This feasibility and reliability study was conducted within the framework of a project previously described in a published study protocol [
26]. This protocol outlines the stepwise translation, cultural adaptation, and validation of the OA-QI questionnaire [
23] for use in Germany and Italy. Although the feasibility phase reported here was not separately registered, it represents the first step of a larger program of research that is registered in the ISRCTN registry (ISRCTN93874734) and includes a planned combined South Tyrol–Salzburg cohort.
2.4. Instruments
2.4.1. Osteoarthritis Quality Indicator Questionnaire (OA-QI v3)
The OA-QI questionnaire was originally developed and validated in Norway [
23] and has since been applied internationally to evaluate the implementation of guideline-recommended care for hip and knee OA [
35,
39]. The most recent version, OA-QI v3, was developed under the leadership of Nina Østerås, together with an international working group, including two of the authors of the current study (A. Z.-N. and C. J. W.). The English OA-QI v3 builds on OA-QI v2 [
23] by broadening the context of information sources, refining the wording of several questions (notably weight advice, work, non-steroidal anti-inflammatory drugs (NSAIDs), and side effect-related questions), and restructuring the numbering of items. OA-QI v3 specified the question regarding medication uptake by asking if NSAIDs were the first medication recommended and listing examples, while the side effects question is reframed in terms of actual use. Version 3 also clarifies the scope of work (paid or unpaid) and introduces slight wording changes for improved clarity. Overall, OA-QI v3 maintained the same 17 core indicators but with more precise wording and reorganized numbering. The OA-QI v3 has not yet been formally published.
The questionnaire covered the following domains of OA management:
Information and counseling: provision of information about OA and treatment options; advice and instruction on exercise; counseling on coping and daily management; and advice and support for weight reduction (if overweight).
Assessment: evaluation of pain, activity limitations, and need for walking aids; discussion of occupational aspects.
Follow-up and pharmacological treatment: control visits; prescription of NSAIDs and information on side effects; and corticosteroid injections and information on side effects.
Surgical treatment: Information about and/or referral for joint replacement surgery.
Each item has three response options: (i) Yes (the indicator was achieved). (ii) No (the indicator was not achieved). (iii) Not relevant/do not remember (the indicator was not applicable).
Following established scoring procedures, items marked “not relevant/do not remember” were treated as “not eligible” and excluded from the denominator of the percentage calculation. For each participant, an individual OA-QI achievement score was calculated (Equation 1).
Patients with fewer than four eligible items were excluded from the analysis to avoid unstable estimates. At the item level, achievement rates were expressed as the percentage of eligible patients responding “Yes.” At the patient level, achievement was summarized using the mean, standard deviation, median, and interquartile range. Distributions were checked for floor and ceiling effects, defined as >15% of patients scoring 0% or 100%. For comparability, the analytic procedures followed those reported in the validation study from Norway [
23] and the application in the Netherlands [
35].
OA-QI v3 Translation and Adaptation
The German (OA-QI v2-D) and Italian (OA-QI v2-I) versions of the OA-QI were initially produced by a professional translation agency (Wilkens Translation Agency, Leiden, Netherlands) specializing in medical translations and certified according to ISO 9001, ISO 17100, and ISO 13485. For the present study, these versions were adapted to the updated OA-QI v3, and translated from English into German and Italian by native-speaking translators. No back-translation was performed because the main work was performed by a certified medical translation provider. Subsequently, both language versions (OA-QI v3-D and OA-QI v3-I) were reviewed by two rheumatologists who were native speakers of German (C.D.) and Italian (M.L.). This step ensured cultural appropriateness and patient comprehensibility, with terms adapted for clarity, such as rendering “NSAIDs” as “schmerzstillende Entzündungshemmer” in German and “farmaci antidolorifici e antiinfiammatori” in Italian (
Table S1).
2.4.2. Additional Variables
In addition to the 17 OA-QI items, the primary questionnaire gathered data on the clinical characteristics of OA and the sociodemographic factors of the participants.
Among the clinical variables, patients reported whether they had ever received a formal diagnosis of OA and indicated the frequency of joint pain (daily, weekly, rarely, or never). They were asked to specify the joints most affected (left or right hip, left or right knee, or other joints) and whether their pain impaired daily activities, with response options ranging from “no” to “constantly.” Further items assessed the use of physiotherapy or exercise therapy (yes/no) and whether the patients had undertaken lifestyle changes due to OA (no, more physical activity, dietary changes, or both). The questionnaire also inquired about the presence of comorbidities (no/yes, with specification) and the duration of symptoms, with response categories ranging from less than 1 year to > 20 years. A detailed history of joint replacement surgery was collected, including recommendations or operations performed on the hip or knee, with the year of surgery, if applicable. Finally, patients were asked about their sources of information on OA and its treatment, with options including GPs, orthopedic surgeons, rheumatologists, physiotherapists, nurses, pharmacists, other patients, family or friends, and the Internet or social media.
Sociodemographic information included year of birth, sex (male, female, diverse, or prefer not to answer), native language (German, Italian, Ladin, or other), educational attainment (compulsory school, vocational training, high school, or university degree), and employment status (full-time, part-time, retired, unemployed, or other). Additionally, patients were asked to rate their subjective economic situation on a five-point scale ranging from “very good” to “very difficult.”
2.5. Comprehensibility and Acceptability Questionnaire
To evaluate comprehensibility and acceptability, a stand-alone questionnaire was administered to a predefined subsample of patients, with one participant per practice site. This instrument included items assessing the overall clarity of the OA-QI questions, ranging from "very well understandable" to "not understandable," the presence of questions perceived as difficult, and the identification of unclear terms. Additional items addressed the ease of completing the questionnaire, from "very easy" to "very difficult," the perceived time burden, and the comprehensibility of the response options. Furthermore, patients were invited to provide open-ended feedback on the wording and potential improvements.
Patients were selected according to the study protocol, with one patient per participating practice invited to complete a comprehensibility module. German- and Italian-speaking patients were included to ensure the representation of the bilingual study setting. Analyses were conducted overall and stratified by language subgroups. Responses to the four-point and dichotomous scales were summarized descriptively, and open-text feedback was reviewed qualitatively to identify recurring issues and suggestions for improvement.
2.6. Retest for Reliability
Test–retest reliability was assessed in a predefined subsample of patients, with two participants per practice invited to complete the OA-QI questionnaire again after approximately 14 days. The retest questionnaire repeated the 17 OA-QI items and included four additional questions on consultations with healthcare professionals, interim changes in osteoarthritis symptoms, new or modified medication, and other treatments initiated since the first administration. Participant responses were excluded from the test-retest analyses if they had visited a general practitioner, medical specialist, or physiotherapist during the interim period. Patients were identified by a combined practice and patient ID, allowing linkage between baseline and retest responses.
2.7. Statistical Analyses
All analyses were performed using IBM SPSS Statistics (version 27.0; IBM Corp., Armonk, NY, USA). Data were screened for completeness and plausibility; patients with missing responses on all OA-QI items or fewer than four eligible items were excluded from the study. Descriptive statistics (frequencies, percentages, means with standard deviations (SD), medians with interquartile ranges (IQR) were used to summarize the sample characteristics, OA-QI item responses, and overall achievement scores. Floor and ceiling effects were defined as >15% of patients scoring 0% or 100% on the patient-reported outcome measure, respectively. Bivariate associations between OA-QI achievement scores and patient characteristics were examined using correlation analyses (Spearman’s rank correlation coefficient for ordinal and categorical variables, and Pearson’s correlation coefficient for continuous age). Effect sizes were interpreted according to Cohen’s thresholds.
The test–retest reliability of OA-QI v3 was assessed in a predefined stable subsample. Item-level agreement was quantified using percent agreement and Cohen’s kappa (κ) with 95% confidence intervals, as interpreted by Landis and Koch [
40]. For the overall achievement score, intraclass correlation coefficients (ICC; two-way mixed effects, absolute agreement) were calculated. Measurement error was further characterized using the standard error of measurement (SEM) and the smallest detectable change (SDC) at the individual and group levels, derived from ICC and the pooled SD.
Multivariable mixed-effects linear regression models were fitted with the OA-QI achievement score (%) as the dependent variable to assess independent associations with sociodemographic, clinical, and contextual characteristics. Predictors included age (continuous), sex (female vs. male), education (ordinal, per higher category), economic status (ordinal, higher values indicating worse status), comorbidity (≥1 chronic disease vs. none), prior joint surgery (yes/no), number of affected joints (0–4), pain frequency, activity limitation, duration of symptoms, language group (Italian, Ladin, or other vs. German as the reference), and number of information sources. A random intercept for general practitioners accounted for clustering within practices. Since each patient contributed only one observation, no random effect for patient ID was necessary. Models were estimated using restricted maximum likelihood (REML) with robust standard errors. The intraclass correlation coefficient (ICC) was calculated to quantify the proportion of variance in OA-QI scores attributable to practice-level clustering. Multicollinearity was assessed using variance inflation factors (VIF), and model fit was evaluated using –2 log likelihood (–2LL), Akaike’s Information Criterion (AIC), and Bayesian Information Criterion (BIC).
All statistical tests were two-sided, and p-values < 0.05 were considered statistically significant.
3. Results
3.1. Study Population
A total of 40 GPs from the SAMNET were invited to participate in the study. Of these, 38 practices actively recruited patients, while 2 did not contribute, resulting in an overall GP participation rate of 95.0%. A total of 266 patients with hip or knee osteoarthritis were enrolled, corresponding to 95.0% of the planned sample size of 280 participants. All included patients completed the OA-QI questionnaire, with subsamples further completing the comprehensibility module (
n = 38) and test–retest reliability assessment (
n = 73). Among the 73 participants’ retest responses at a two-week interval, 37 (48%) were excluded from the test-retest analyses because they had visited a general practitioner, medical specialist, or physiotherapist in the interim period. The test–retest subsample (
n = 36) appeared broadly representative of the larger study cohort with respect to age, sex, language, employment, comorbidity, and most clinical variables. It contained proportionally more patients with prior joint replacement and somewhat higher educational attainment (
Table 1).
The sociodemographic and clinical characteristics of the study population are shown in
Table 1. The mean age was 71.9 years (SD 10.3), and 58.6% of the participants were female. Most patients reported German as their mother tongue (61.3%), followed by Italian (32.3%), Ladin (2.3%), and other languages (4.1%). Educational attainment varied, with 16.5% having completed only compulsory schooling, 22.9% vocational training, 37.6% secondary school, and 23.0% higher education or university. Most patients were retired (69.9%), with smaller proportions employed full-time (14.7%) or part-time (9.4%) jobs. Among patients with valid responses (n = 266), 35.3% rated their financial situation as very good or good, 52.6% as moderate, and 12.0% as poor or very poor. Clinically, 47.9% of the patients reported right knee involvement and 34.3% reported left knee involvement, 26.7% had previously undergone joint replacement surgery, and 61.5% reported at least one chronic comorbidity.
Patients most frequently reported their general practitioner (65.4%) and orthopedic surgeon (50.4%) as sources of information on OA, followed by physiotherapists (16.5%). Only a minority mentioned other sources, including rheumatologists (7.5%), the internet or media (5.3%), family or friends (4.9%), pharmacists (1.5%), nurses (0.8%), or other patients (0.8%). While 55.3% of patients reported using a single source of information, 27.4% used two sources, 10.9% used three sources, and only small proportions reported four (3.8%) or five (0.8%) different sources. Regarding the absence of information, 7.9% explicitly indicated that they had not received information from any source, yet only 1.9% had no source recorded at all, suggesting that some participants marked both “no source” and at least one source, resulting in inconsistent responses.
3.2. OA-QI Achievement Scores
At the item level, the proportion of patients who reported receiving recommended care varied widely across the 17 OA-QI indicators (
Table 2). The highest achievement rates were observed for advice on physical activity (81.6%), NSAID prescription (80.3%), and assessment of joint pain (77.2%). In contrast, the lowest rates were recorded for discussions on occupational aspects (18.2%), support for weight reduction (33.5%), and assessment of the need for walking aids (31.0%).
At the patient level, the mean OA-QI achievement score was 58.7% (SD 28.5), with a median score of 60.8% (IQR 35.3–84.9). This distribution indicates that, on average, patients reported receiving slightly more than half of the recommended quality indicators, with marked variability across individuals.
Floor and ceiling analyses showed that only 1.5% of patients scored 0% and 8.3% achieved the maximum score of 100%. As both values were below the predefined 15% threshold, no floor or ceiling effects were observed.
3.3. Comprehensibility and Acceptability
Among the 38 patients who completed the comprehensibility and acceptability module, 94.7% rated all questions as “very understandable” or “rather understandable,” while 5.3% considered at least some items to be difficult. A total of 10.5% of the participants reported that individual questions were difficult to understand, and 18.4% noted unclear terms. Regarding ease of completion, 94.7% described the questionnaire as “very easy” or “rather easy,” whereas 5.3% found it difficult, and 10.5% felt that completing the questionnaire took too long. Finally, 86.8% of the participants considered the response categories to be clear and appropriate, whereas 13.2% indicated difficulties with them.
There were only three comments in the open-text fields. Two respondents mentioned that they found the German and Italian terms for "osteoarthritis" challenging to comprehend, while one patient pointed out that some questions seemed redundant. These remarks did not concern the OA-QI items but additional sociodemographic and clinical variables that had been included in the questionnaire.
3.4. Test–Retest Reliability
The test–retest reliability was evaluated among 36 participants who remained stable and did not consult a healthcare professional during the interim period. For the overall OA-QI achievement score, the intraclass correlation coefficient (ICC, two-way mixed effects, absolute agreement, single measures) was 0.55 (95% CI 0.28–0.74; p < 0.001), indicating moderate reliability. The corresponding Cronbach’s alpha for the two measurement occasions was 0.71. The standard error of measurement (SEM) was 20.7, resulting in the smallest detectable change (SDC) of 57.3 points at the individual level and 9.6 points at the group level (n = 36).
At the item level, κ values ranged from 0.33 to 0.69, with percent agreement between 61.1% and 86.1% (
Table 3), indicating acceptable reliability. Most items demonstrated moderate reliability, with several reaching substantial reliability. Information items showed κ = 0.51 for information about osteoarthritis and κ = 0.53 for information about treatment options. Self-management advice also yielded substantial reliability (κ = 0.64). The item on receiving help for weight loss, which previously showed poor agreement, now had fair reliability (κ = 0.38). Items regarding pharmacological treatment and side effects demonstrated only fair to moderate agreement, with κ values of approximately 0.40–0.46. The newly added version 3 item on surgical referral achieved moderate reliability (κ = 0.55).
3.5. Associations with Additional Variables
At the bivariate level, OA-QI achievement scores were largely unrelated to age, sex, pain frequency, activity limitation, symptom duration, number of joints affected, or prior surgery. In contrast, several sociodemographic and contextual factors showed small but significant associations. Italian-speaking patients reported higher OA-QI scores than German speakers (ρ ≈ 0.13, p = 0.03), while vocational and university education were associated with lower scores than mid-level education (ρ = –0.17 to –0.24, p ≤ 0.02). Patients in full-time employment and those who rated their financial situation as poor also reported lower OA-QI scores (ρ ≈ –0.12 to –0.18, p ≤ 0.05). The presence of at least one chronic comorbidity was correlated with reduced OA-QI scores (ρ = –0.13, p = 0.045).
The strongest positive associations were observed for information behavior: both the number of information sources used (ρ = 0.34,
p < 0.001) and categorized information use (none, one, ≥2 sources; ρ = 0.32,
p < 0.001) correlated with higher OA-QI scores. Overall, these findings suggest that patient education, language, socioeconomic context, and access to information play a more important role in reported care quality than clinical severity. An overview of the correlation results is presented in
Table 4.
Multivariable Mixed-Effects Linear Regression
Regression analyses were conducted to examine independent associations between patient characteristics and OA-QI achievement scores, while accounting for clustering at the practice level.
Results are shown in
Table 5. Female patients had significantly lower OA-QI scores than male patients (β = –6.18, 95% CI –11.62 to –0.74;
p = 0.026). Each higher level of education was associated with an average 2.65-point higher OA-QI score (95% CI 0.81–4.49;
p = 0.005). Greater activity limitation was independently associated with lower OA-QI scores (β = –3.71, 95% CI –6.19 to –1.23;
p = 0.004). No significant associations were observed between age, economic status, comorbidity, prior surgery, number of affected joints, pain frequency, symptom duration, or language group.
The intraclass correlation coefficient (ICC) indicated that approximately 6% of the variance in OA-QI scores was attributable to differences between GP practices. Collinearity diagnostics indicated no evidence of problematic multicollinearity, with all VIF values < 1.5 and tolerance values > 0.7. The model fit statistics indicated an adequate fit (–2LL = 2276.9, AIC = 2280.9, BIC = 2287.9).
4. Discussion
This feasibility study introduced the OA-QI questionnaire version 3 in German and Italian to South Tyrol general practice and confirmed its applicability and reliability in the healthcare context. The achievement of quality indicators varied, with high rates for physical activity advice, NSAID prescription, and joint pain assessment, but low attainment for weight reduction support, occupational aspects discussion, and walking aid needs assessment. The mean achievement score was 58.7%, indicating that slightly more than half of the recommended indicators were met. Test–retest analyses showed fair to substantial reliability at the item level (κ range 0.33–0.69, agreement 61–86%), with the new surgical referral item showing moderate stability. At the total-score level, reliability was moderate (ICC = 0.55, 95% CI 0.28–0.74), with a standard error of measurement of 20.7 and smallest detectable change of 57.3 points at the individual level (9.6 at the group level). These results indicate that while OA-QI v3 can detect small changes in group-level achievement scores (≈10 percentage points), changes in individual patients must exceed 57 percentage points to be distinguished from the measurement error.
The main objective was to determine whether OA-QI v3 could be implemented in routine general practice, whether it was acceptable to patients, and whether it demonstrated reliability in this cultural and organizational setting in South Tyrol. Recruitment of targeted general practitioners and patients demonstrated the practicality of integrating the instrument into daily workflows. Patient feedback confirmed high comprehensibility and ease of completion in German and Italian, indicating their suitability for bilingual regions. The patterns of missingness were low, although items such as occupational aspects and weight management were less frequently applicable, reflecting domain relevance in the local context. The test–retest findings at the item and total score levels support the instrument's stability and reliability. These feasibility outcomes demonstrate that OA-QI v3 is practicable in South Tyrol and generates consistent results that can serve as a basis for broader applications and international benchmarking of OA care.
4.1. Feasibility, Reliability, and Comparison with Other OA-QI Versions
The findings of this study confirm that OA-QI v3 is feasible and reliable in South Tyrol, with high patient acceptability using German or Italian translations. These results extend the evidence base of the OA-QI, which has undergone a staged process of development, revision, and cross-cultural adaptation since its inception. The original Norwegian OA-QI demonstrated content validity and fair-to-substantial reliability (κ = 0.20–0.80, agreement = 62–90%) [
41]. A revised version (OA-QI v2) further improved the measurement properties, showing excellent reliability at the total score level (ICC = 0.89), acceptable construct validity, and responsiveness suitable for evaluative purposes [
23]. The present findings of moderate total score reliability and item-level stability are consistent with the literature, confirming their applicability in a new bilingual setting.
Several language versions have been developed internationally. The Dutch translation followed forward–backward procedures and pre-testing with patient representatives, resulting in an 18-item version with acceptable internal consistency (α = 0.79) and achievement patterns similar to those observed in other countries [
35]. The OA-QI has also been applied in Portuguese and English in cross-country comparisons with consistent psychometric performance [
42]. In the United Kingdom, a patient-reported OA-QI (UK) was developed with the strong involvement of a Research User Group as part of the MOSAICS study, harmonizing several items with the Norwegian version and aligning the instrument with the NICE quality standards [
24]. These parallel developments highlight the adaptability of OA-QI instruments to local contexts while retaining their core international comparability.
The German and Italian versions were prepared through professional translation, followed by adaptation by native-speaking rheumatologists in accordance with the recommended cross-cultural adaptation procedures [
35,
42,
43]. Acceptability and reliability were confirmed using patient feedback and retesting at the pooled level. Given the small number of Italian-speaking participants (<10), subgroup analyses of acceptability and reliability would have been statistically underpowered. Future studies with larger Italian-speaking samples are needed to confirm the measurement equivalence across languages.
4.2. Interpretation and Comparison with Previous Literature
Across international primary care systems, the results of this survey replicate a well-described pattern in OA quality indicator achievement: relatively high delivery of lifestyle/exercise advice and routine pharmacotherapy, contrasted with persistent shortfalls in weight management support, occupational guidance, and assessment for assistive devices. Concordant findings have been reported in multi-country surveys and systematic reviews from the United Kingdom, Netherlands, Canada, Australia, Denmark, Norway, Portugal, and Singapore, suggesting system-wide rather than region-specific implementation gaps [
21,
22,
42,
44,
45,
46,
47,
48]. Patient-reported assessments echo these discrepancies, with many individuals indicating insufficient information and support for non-pharmacological care [
24,
42,
44,
45].
While average achievement is suboptimal across settings, specific profiles vary, likely reflecting differences in local priorities, access to multidisciplinary services and system design [
42,
44,
46]. The recurrent under-delivery of weight-loss support and functional/assistive assessments aligns with evidence that indicators fitting established workflows (exercise advice, NSAID prescribing) are easier to operationalize, whereas indicators requiring coordinated behavior change or multidisciplinary input (weight management, occupational advice, walking-aid assessment) face greater barriers [
49,
50,
51,
52,
53,
54,
55].
Taken together, the international literature positions our results within a consistent cross-system profile of strengths in lifestyle and basic pharmacologic management and persistent gaps in weight, work/role, and assistive device domains. These gaps are plausibly driven by structural constraints (time, referral pathways, reimbursement, limited integration of physiotherapy/occupational therapy), as well as clinician and patient beliefs that dampen the uptake of recommended non-pharmacologic care [
51,
52,
53,
54]. This comparison underscores the need for targeted implementation strategies in South Tyrol, embedding multidisciplinary pathways, practical weight-management support, and consistent assessment of functional aids so that guideline priorities translate into routine primary care.
4.3. Implications for Clinical Practice and Quality Monitoring
The study demonstrates that the bilingual OA-QI is suitable for use in South Tyrolean general practice, offering a reliable and patient-friendly way to assess care quality and highlight differences across the domains of OA management. In daily practice, the instrument can help general practitioners systematically identify gaps and address them more effectively, such as in weight management, occupational aspects, and assistive device provision.
The OA-QI is particularly valuable for quality monitoring at the group level. While individual-level reliability is limited, requiring very large changes in scores to exceed measurement error, group-level reliability is strong and allows for the meaningful detection of smaller changes in average scores. This mirrors the findings from the revised Norwegian OA-QI v2, where group-level reliability was excellent, but the measurement error at the individual level was high [
23]. Similar patterns have been reported for other patient-reported instruments, including the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), Knee Injury and Osteoarthritis Outcome Score (KOOS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Osteoarthritis Knee and Hip Quality of Life questionnaire (OAKHQOL), and Osteoarthritis Quality of Life scale (OAQoL). These measures consistently show high reliability and validity for group comparisons but limited responsiveness for tracking individual patients [
56,
57,
58,
59,
60,
61,
62,
63].
Aggregated OA-QI results can thus form a basis for practice-level quality work, regional training initiatives, and benchmarking across practices and internationally [
23,
24,
35]. In this way, the instrument contributes to both transparency and quality-oriented improvement efforts.
4.4. Strengths and Limitations
This study is the first to apply the OA-QI v3 in a bilingual healthcare setting, demonstrating its feasibility in South Tyrolean general practice. The recruitment rates were high, missing data were low, and patient feedback confirmed good comprehensibility. Feasibility studies typically do not require formal power calculations; however, guidance emphasizes stable estimates for recruitment, acceptability, and missingness [
30,
37]. Reliability was assessed using multiple metrics, and the findings replicated international patterns of OA care quality, with strengths in lifestyle advice and pharmacotherapy but gaps in weight management and functional support.
However, several limitations temper these strengths. The study was conducted in a motivated GP network (SAMNET), which may limit its generalizability. As this study was conceived as a feasibility pilot rather than a full validation, certain elements of the published protocol [
26] could not be implemented, such as the language-specific reliability testing. Nevertheless, this process provided important lessons, including the risk of dropout in retest groups due to clinical instability. The retest subgroup differed from the full cohort (e.g., more post-surgery patients and educational differences), and because approximately half had contact with a healthcare professional during the interval, indicating potential changes in their clinical status, the effective sample for reliability analyses was small. This underscores the need to account for patient stability when planning retest studies. Finally, reliance on retrospective self-reports carries the risk of recall bias.
The planned cross-national study in South Tyrol and Austria should follow the original protocol [
26], ensure larger and clinically stable subgroups for test–retest analyses, and include cognitive debriefing in the study design. Broader psychometric testing, including responsiveness and construct validity, is needed to establish the OA-QI as a robust tool for quality monitoring and international benchmarking.
5. Conclusions
This feasibility pilot demonstrated that the German and Italian OA-QI v3 can be integrated into South Tyrolean general practice, with high patient acceptability and adequate reliability for group-level monitoring. Achievement rates revealed strengths in lifestyle advice, pharmacological management, and pain assessment but persistent shortfalls in weight reduction support, occupational aspects, and assistive device provision, mirroring international patterns. The study showed that the OA-QI is most reliable for evaluating care quality at the group level, whereas measurement error limits its use for monitoring individual patients. Lessons learned from the retest phase, particularly the influence of subgroup composition and clinical instability on reliability estimates, are directly relevant for future validation studies. Overall, the findings support the OA-QI as a practical and informative tool for identifying care gaps, guiding quality improvement, and enabling international benchmarking. Cross-national validation in Italy and Austria will be necessary to establish full psychometric evidence for the German and Italian versions.
Supplementary Materials
The following supporting information can be downloaded at the website of this paper posted on Preprints.org, Table S1: OA-QI v3 Items in English, German, and Italian.
Author Contributions
Conceptualization, A.E., G.P., M.R. and C.J.W.; methodology, A.Z., C.D, M.L., N. Ø. and C.J.W.; formal analysis, C.J.W.; investigation, P.M., A.M., S.W. and J.F.; data curation, P.M. and C.J.W.; writing—original draft preparation, C.J.W.; writing—review and editing, M.R., A.M., S.W., J.F., C.D., M.L., A.E., G.P. and N. Ø.; funding acquisition, C.J.W. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the South Tyrolean Fund for the Promotion of Scientific Research (SFPR), grant number J53C24004050003. The APC was funded by the Institute of General Practice and Public Health, Claudiana – College of Health Professions, Bolzano, Italy.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Azienda Sanitaria dell’Alto Adige, Bolzano (protocol code 103-2022, date of approval 20 October 2022).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Data are available from the corresponding author upon reasonable request.
Acknowledgments
Generative AI tools, specifically ChatGPT (OpenAI), were used to support the structuring and linguistic refinement of the manuscript, including improved clarity and consistency in the Methods section and other descriptive parts of the text. AI assistance was used to generate and refine SPSS syntax for data preparation and analysis. All statistical computations and analyses were then conducted and verified by the authors. No AI tools were used for the execution of data analysis, statistical computation, or interpretation of results. The authors have reviewed and edited the output and take full responsibility for the content of this publication. The authors are grateful to the physicians of the South Tyrolean General Practice Research Network (SAMNET) for their commitment to patient recruitment and study implementation.
Conflicts of Interest
The authors declare no conflicts of interest.
Abbreviations
The following abbreviations are used in this manuscript:
| –2LL |
–2 log likelihood |
| AIC |
Akaike’s Information Criterion |
| BIC |
Bayesian Information Criterion |
| CI |
Confidence Interval |
| D |
German |
| EQ-5D-5L |
EuroQol 5-Dimension 5-Level |
| GP |
General practitioner |
| HOOS |
Hip disability and Osteoarthritis Outcome Score |
| I |
Italian |
| ICC |
Intraclass Correlation Coefficient |
| IQR |
Interquartile Range |
| ISRCTN |
International Standard Randomised Controlled Trial Number |
| KOOS |
Knee injury and Osteoarthritis Outcome Score |
| NICE |
National Institute for Health and Care Excellence |
| NSAID |
Non-steroidal anti-inflammatory drug |
| OA |
Osteoarthritis |
| OAKHQOL |
Osteoarthritis Knee and Hip Quality of Life |
| OA-QI |
Osteoarthritis Quality Indicators |
| OAQoL |
Osteoarthritis Quality of Life |
| REML |
Restricted Maximum Likelihood |
| SAMNET |
South Tyrolean General Practice Research Network |
| SD |
Standard Deviation |
| SDC |
Smallest Detectable Change |
| SEM |
Standard Error of Measurement |
| VIF |
Variance Inflation Factor |
References
- GBD 2021 Osteoarthritis Collaborators Global, Regional, and National Burden of Osteoarthritis, 1990-2020 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol 2023, 5, e508–e522. [CrossRef]
- Giorgino, R.; Albano, D.; Fusco, S.; Peretti, G.M.; Mangiavini, L.; Messina, C. Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update. Int J Mol Sci 2023, 24, 6405. [Google Scholar] [CrossRef]
- Moseng, T.; Vliet Vlieland, T.P.M.; Battista, S.; Beckwée, D.; Boyadzhieva, V.; Conaghan, P.G.; Costa, D.; Doherty, M.; Finney, A.G.; Georgiev, T.; et al. EULAR Recommendations for the Non-Pharmacological Core Management of Hip and Knee Osteoarthritis: 2023 Update. Ann Rheum Dis 2024, 83, 730–740. [Google Scholar] [CrossRef] [PubMed]
- Faber, B.G.; Macrae, F.; Jung, M.; Zucker, B.E.; Beynon, R.A.; Tobias, J.H. Sex Differences in the Radiographic and Symptomatic Prevalence of Knee and Hip Osteoarthritis. Front Endocrinol (Lausanne) 2024, 15, 1445468. [Google Scholar] [CrossRef]
- Sharma, L. Osteoarthritis of the Knee. N Engl J Med 2021, 384, 51–59. [Google Scholar] [CrossRef]
- Katz, J.N.; Arant, K.R.; Loeser, R.F. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA 2021, 325, 568–578. [Google Scholar] [CrossRef]
- Bannuru, R.R.; Osani, M.C.; Vaysbrot, E.E.; Arden, N.K.; Bennell, K.; Bierma-Zeinstra, S.M.A.; Kraus, V.B.; Lohmander, L.S.; Abbott, J.H.; Bhandari, M.; et al. OARSI Guidelines for the Non-Surgical Management of Knee, Hip, and Polyarticular Osteoarthritis. Osteoarthritis Cartilage 2019, 27, 1578–1589. [Google Scholar] [CrossRef]
- Roos, E.M.; Arden, N.K. Strategies for the Prevention of Knee Osteoarthritis. Nat Rev Rheumatol 2016, 12, 92–101. [Google Scholar] [CrossRef] [PubMed]
- Hitzl, W.; Stamm, T.; Kloppenburg, M.; Ritter, M.; Gaisberger, M.; van der Zee-Neuen, A. Projected Number of Osteoarthritis Patients in Austria for the next Decades - Quantifying the Necessity of Treatment and Prevention Strategies in Europe. BMC Musculoskelet Disord 2022, 23, 133. [Google Scholar] [CrossRef] [PubMed]
- Hinman, R.S.; Hall, M.; Comensoli, S.; Bennell, K.L. Exercise & Sports Science Australia (ESSA) Updated Position Statement on Exercise and Physical Activity for People with Hip/Knee Osteoarthritis. J Sci Med Sport 2023, 26, 37–45. [Google Scholar] [CrossRef]
- Zampogna, B.; Papalia, R.; Papalia, G.F.; Campi, S.; Vasta, S.; Vorini, F.; Fossati, C.; Torre, G.; Denaro, V. The Role of Physical Activity as Conservative Treatment for Hip and Knee Osteoarthritis in Older People: A Systematic Review and Meta-Analysis. J Clin Med 2020, 9, 1167. [Google Scholar] [CrossRef]
- Skou, S.T.; Pedersen, B.K.; Abbott, J.H.; Patterson, B.; Barton, C. Physical Activity and Exercise Therapy Benefit More Than Just Symptoms and Impairments in People With Hip and Knee Osteoarthritis. J Orthop Sports Phys Ther 2018, 48, 439–447. [Google Scholar] [CrossRef]
- Kraus, V.B.; Sprow, K.; Powell, K.E.; Buchner, D.; Bloodgood, B.; Piercy, K.; George, S.M.; Kraus, W.E. ; 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE* Effects of Physical Activity in Knee and Hip Osteoarthritis: A Systematic Umbrella Review. Med Sci Sports Exerc 2019, 51, 1324–1339. [Google Scholar] [CrossRef]
- Goh, S.-L.; Persson, M.S.M.; Stocks, J.; Hou, Y.; Welton, N.J.; Lin, J.; Hall, M.C.; Doherty, M.; Zhang, W. Relative Efficacy of Different Exercises for Pain, Function, Performance and Quality of Life in Knee and Hip Osteoarthritis: Systematic Review and Network Meta-Analysis. Sports Med 2019, 49, 743–761. [Google Scholar] [CrossRef]
- Qi, W.; Alarcón, D.; Arenilla, M.J.; Yu, H.; Jaenes, J.C.; Trujillo, M.; Wilczyńska, D. A Systematic Review and Meta-Analysis of Asian Exercise Techniques and Various Physical Activity Interventions in Middle and Late Adulthood Patients With Knee Osteoarthritis. J Aging Phys Act 2025, 33, 387–398. [Google Scholar] [CrossRef] [PubMed]
- Whitfield, M.; Tomlinson, O.W. Optimal Exercise Modalities and Doses for Therapeutic Management of Osteoarthritis of the Knee. Front Aging 2025, 6, 1458983. [Google Scholar] [CrossRef] [PubMed]
- Regnaux, J.-P.; Lefevre-Colau, M.-M.; Trinquart, L.; Nguyen, C.; Boutron, I.; Brosseau, L.; Ravaud, P. High-Intensity versus Low-Intensity Physical Activity or Exercise in People with Hip or Knee Osteoarthritis. Cochrane Database Syst Rev 2015, 2015, CD010203. [Google Scholar] [CrossRef]
- Nissen, N.; Holm, P.M.; Bricca, A.; Dideriksen, M.; Tang, L.H.; Skou, S.T. Clinicians’ Beliefs and Attitudes to Physical Activity and Exercise Therapy as Treatment for Knee and/or Hip Osteoarthritis: A Scoping Review. Osteoarthritis Cartilage 2022, 30, 260–269. [Google Scholar] [CrossRef]
- Gay, C.; Chabaud, A.; Guilley, E.; Coudeyre, E. Educating Patients about the Benefits of Physical Activity and Exercise for Their Hip and Knee Osteoarthritis. Systematic Literature Review. Ann Phys Rehabil Med 2016, 59, 174–183. [Google Scholar] [CrossRef] [PubMed]
- Kanavaki, A.M.; Rushton, A.; Efstathiou, N.; Alrushud, A.; Klocke, R.; Abhishek, A.; Duda, J.L. Barriers and Facilitators of Physical Activity in Knee and Hip Osteoarthritis: A Systematic Review of Qualitative Evidence. BMJ Open 2017, 7, e017042. [Google Scholar] [CrossRef]
- Arslan, I.G.; Rozendaal, R.M.; Middelkoop, M. van; Stitzinger, S.A.G.; Kerkhove, M.-P.V. de; Voorbrood, V.M.I.; Bindels, P.J.E.; Bierma-Zeinstra, S.M.A.; Schiphof, D. Quality Indicators for Knee and Hip Osteoarthritis Care: A Systematic Review. RMD Open 2021, 7. [Google Scholar] [CrossRef]
- Edwards, J.J.; Khanna, M.; Jordan, K.P.; Jordan, J.L.; Bedson, J.; Dziedzic, K.S. Quality Indicators for the Primary Care of Osteoarthritis: A Systematic Review. Ann Rheum Dis 2015, 74, 490–498. [Google Scholar] [CrossRef]
- Østerås, N.; Tveter, A.T.; Garratt, A.M.; Svinøy, O.E.; Kjeken, I.; Natvig, B.; Grotle, M.; Hagen, K.B. Measurement Properties for the Revised Patient-Reported OsteoArthritis Quality Indicator Questionnaire. Osteoarthritis Cartilage 2018, 26, 1300–1310. [Google Scholar] [CrossRef]
- Blackburn, S.; Higginbottom, A.; Taylor, R.; Bird, J.; Østerås, N.; Hagen, K.B.; Edwards, J.J.; Jordan, K.P.; Jinks, C.; Dziedzic, K. Patient-Reported Quality Indicators for Osteoarthritis: A Patient and Public Generated Self-Report Measure for Primary Care. Res Involv Engagem 2016, 2, 5. [Google Scholar] [CrossRef]
- Bock, T.; Flemming, R.; Bammert, P.; von Eisenhart-Rothe, R.; Hirschmann, M.T.; Sundmacher, L. Routine-Data-Compatible Quality Indicators for the Ambulatory Care of Osteoarthritis of the Knee and Hip: A Systematic Review. Knee Surg Sports Traumatol Arthrosc 2025. [Google Scholar] [CrossRef] [PubMed]
- Wiedermann, C.J.; Marino, P.; van der Zee-Neuen, A.; Mastrobuono, I.; Mahlknecht, A.; Barbieri, V.; Wildburger, S.; Fuchs, J.; Capici, A.; Piccoliori, G.; et al. Patient-Reported Quality of Care for Osteoarthritis in General Practice in South Tyrol, Italy: Protocol for Translation, Validation and Assessment of the OsteoArthritis Quality Indicator Questionnaire (OA-QI). Methods Protoc 2023, 6. [Google Scholar] [CrossRef] [PubMed]
- Battista, S.; Recenti, F.; Giardulli, B.; Testa, M.; Pchelnikova, P.; Ndosi, M.; Dell’Isola, A. Geographical Differences in the Perspective of Osteoarthritis Care Management: A Cross-Sectional Study in Italy, Sweden and Russia. Musculoskeletal Care 2024, 22, e1934. [Google Scholar] [CrossRef] [PubMed]
- Giaretta, S.; Magni, A.; Migliore, A.; Natoli, S.; Puntillo, F.; Ronconi, G.; Santoiemma, L.; Sconza, C.; Viapiana, O.; Zanoli, G. A Review of Current Approaches to Pain Management in Knee Osteoarthritis with a Focus on Italian Clinical Landscape. J Clin Med 2024, 13, 5176. [Google Scholar] [CrossRef]
- Gómez-Rodríguez, R.; Díaz-Pulido, B.; Gutiérrez-Ortega, C.; Sánchez-Sánchez, B.; Torres-Lacomba, M. Cultural Adaptation and Psychometric Validation of the Standardised Nordic Questionnaire Spanish Version in Musicians. Int J Environ Res Public Health 2020, 17, 653. [Google Scholar] [CrossRef]
- Gjersing, L.; Caplehorn, J.R.M.; Clausen, T. Cross-Cultural Adaptation of Research Instruments: Language, Setting, Time and Statistical Considerations. BMC Med Res Methodol 2010, 10, 13. [Google Scholar] [CrossRef]
- Swami, V.; Barron, D. Translation and Validation of Body Image Instruments: Challenges, Good Practice Guidelines, and Reporting Recommendations for Test Adaptation. Body Image 2019, 31, 204–220. [Google Scholar] [CrossRef]
- Stevelink, S. a. M.; van Brakel, W.H. The Cross-Cultural Equivalence of Participation Instruments: A Systematic Review. Disabil Rehabil 2013, 35, 1256–1268. [Google Scholar] [CrossRef] [PubMed]
- Reichenheim, M.E.; Moraes, C.L. [Operationalizing the cross-cultural adaptation of epidemiological measurement instruments]. Rev Saude Publica 2007, 41, 665–673. [Google Scholar] [CrossRef] [PubMed]
- Südtiroler Allgemeinmedizinisches Forschungsnetzwerk - SAMNET . Available online: https://www.claudiana.bz.it/de/forschung/samnet (accessed on 7 September 2025).
- Oomen, J.M.H.; Peters, Y. a. S.; van den Ende, C.H.; Schers, H.J.; Assendelft, W.J.J.; Vriezekolk, J.E.; Koëter, S. Quality of Knee Osteoarthritis Care in the Netherlands: A Survey on the Perspective of People with Osteoarthritis. BMC Health Serv Res 2022, 22, 631. [Google Scholar] [CrossRef] [PubMed]
- Anthoine, E.; Moret, L.; Regnault, A.; Sébille, V.; Hardouin, J.-B. Sample Size Used to Validate a Scale: A Review of Publications on Newly-Developed Patient Reported Outcomes Measures. Health Qual Life Outcomes 2014, 12, 2. [Google Scholar] [CrossRef]
- Perneger, T.V.; Courvoisier, D.S.; Hudelson, P.M.; Gayet-Ageron, A. Sample Size for Pre-Tests of Questionnaires. Qual Life Res 2015, 24, 147–151. [Google Scholar] [CrossRef]
- Osteoarthritis in over 16s: Diagnosis and Management. Available online: https://www.nice.org.uk/guidance/ng226 (accessed on 7 September 2025).
- Larmer, P.J.; Bennett, K.; Baldwin, J.N.; Bassett, S.; O’Brien, D.W. Quality Indicators for Hip and Knee Osteoarthritis Management in New Zealand: A Patient Survey. New Zealand Journal of Physiotherapy 2019, 47, 183–192. [Google Scholar] [CrossRef]
- Landis, J.R.; Koch, G.G. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977, 33, 159–174. [Google Scholar] [CrossRef]
- Grønhaug, G.; Østerås, N.; Hagen, K.B. Quality of Hip and Knee Osteoarthritis Management in Primary Health Care in a Norwegian County: A Cross-Sectional Survey. BMC Health Serv Res 2014, 14, 598. [Google Scholar] [CrossRef]
- Østerås, N.; Jordan, K.P.; Clausen, B.; Cordeiro, C.; Dziedzic, K.; Edwards, J.; Grønhaug, G.; Higginbottom, A.; Lund, H.; Pacheco, G.; et al. Self-Reported Quality Care for Knee Osteoarthritis: Comparisons across Denmark, Norway, Portugal and the UK. RMD Open 2015, 1, e000136. [Google Scholar] [CrossRef]
- Beaton, D.E.; Bombardier, C.; Guillemin, F.; Ferraz, M.B. Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures. Spine (Phila Pa 1976) 2000, 25, 3186–3191. [Google Scholar] [CrossRef]
- Tan, R.H.L.; Goff, A.J.; Lim, C.J.; Tan, Y.B. Assessing the Quality of Care for Knee Osteoarthritis in Singapore: A Cross-Sectional Study. BMC Musculoskelet Disord 2025, 26, 298. [Google Scholar] [CrossRef] [PubMed]
- Ingelsrud, L.H.; Roos, E.M.; Gromov, K.; Jensen, S.S.; Troelsen, A. Patients Report Inferior Quality of Care for Knee Osteoarthritis Prior to Assessment for Knee Replacement Surgery - a Cross-Sectional Study of 517 Patients in Denmark. Acta Orthop 2020, 91, 82–87. [Google Scholar] [CrossRef] [PubMed]
- Petrosyan, Y.; Sahakyan, Y.; Barnsley, J.M.; Kuluski, K.; Liu, B.; Wodchis, W.P. Quality Indicators for Care of Osteoarthritis in Primary Care Settings: A Systematic Literature Review. Fam Pract 2018, 35, 151–159. [Google Scholar] [CrossRef] [PubMed]
- Basedow, M.; Esterman, A. Assessing Appropriateness of Osteoarthritis Care Using Quality Indicators: A Systematic Review. J Eval Clin Pract 2015, 21, 782–789. [Google Scholar] [CrossRef]
- Hagen, K.B.; Smedslund, G.; Østerås, N.; Jamtvedt, G. Quality of Community-Based Osteoarthritis Care: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken) 2016, 68, 1443–1452. [Google Scholar] [CrossRef]
- Bhardwaj, A.; FitzGerald, C.; Graham, M.; MacFarlane, A.; Kennedy, N.; Toomey, C.M. Barriers and Facilitators to Implementation of an Exercise and Education Programme for Osteoarthritis: A Qualitative Study Using the Consolidated Framework for Implementation Research. Rheumatol Int 2024, 44, 1035–1050. [Google Scholar] [CrossRef]
- Spitaels, D.; Vankrunkelsven, P.; Desfosses, J.; Luyten, F.; Verschueren, S.; Van Assche, D.; Aertgeerts, B.; Hermens, R. Barriers for Guideline Adherence in Knee Osteoarthritis Care: A Qualitative Study from the Patients’ Perspective. J Eval Clin Pract 2017, 23, 165–172. [Google Scholar] [CrossRef]
- Swaithes, L.; Paskins, Z.; Dziedzic, K.; Finney, A. Factors Influencing the Implementation of Evidence-Based Guidelines for Osteoarthritis in Primary Care: A Systematic Review and Thematic Synthesis. Musculoskeletal Care 2020, 18, 101–110. [Google Scholar] [CrossRef]
- Ferreira de Meneses, S.; Rannou, F.; Hunter, D.J. Osteoarthritis Guidelines: Barriers to Implementation and Solutions. Ann Phys Rehabil Med 2016, 59, 170–173. [Google Scholar] [CrossRef]
- Egerton, T.; Diamond, L.E.; Buchbinder, R.; Bennell, K.L.; Slade, S.C. A Systematic Review and Evidence Synthesis of Qualitative Studies to Identify Primary Care Clinicians’ Barriers and Enablers to the Management of Osteoarthritis. Osteoarthritis Cartilage 2017, 25, 625–638. [Google Scholar] [CrossRef]
- Gibbs, A.J.; Barton, C.J.; Taylor, N.F.; Kemp, J.L.; Wallis, J.A.; Manski-Nankervis, J.-A.; Ezzat, A.M. General Practitioners Experience Multi-Level Barriers to Implementing Recommended Care for Hip and Knee Osteoarthritis: A Qualitative Study. BMC Prim Care 2024, 25, 423. [Google Scholar] [CrossRef]
- Cunningham, J.; M Briggs, A.; Cottrell, E.; Doyle, F.; Dziedzic, K.; Finney, A.; Murphy, P.; Paskins, Z.; Sheridan, E.; Swaithes, L.; et al. Barriers and Facilitators to the Implementation of Osteoarthritis Management Programmes in Primary or Community Care Settings: A Systematic Review and Qualitative Framework Synthesis Protocol. HRB Open Res 2021, 4, 102. [Google Scholar] [CrossRef]
- Lundgren-Nilsson, Å.; Dencker, A.; Palstam, A.; Person, G.; Horton, M.C.; Escorpizo, R.; Küçükdeveci, A.A.; Kutlay, S.; Elhan, A.H.; Stucki, G.; et al. Patient-Reported Outcome Measures in Osteoarthritis: A Systematic Search and Review of Their Use and Psychometric Properties. RMD Open 2018, 4, e000715. [Google Scholar] [CrossRef]
- Wilburn, J.; McKenna, S.P.; Kutlay, Ş.; Bender, T.; Braun, J.; Castillo-Gallego, C.; Favero, M.; Geher, P.; Kiltz, U.; Martin-Mola, E.; et al. Adaptation of the Osteoarthritis-Specific Quality of Life Scale (the OAQoL) for Use in Germany, Hungary, Italy, Spain and Turkey. Rheumatol Int 2017, 37, 727–734. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez Sáenz de Tejada, M.; Bilbao, A.; Herrera, C.; García, L.; Sarasqueta, C.; Escobar, A. Validation of the Mini-OAKHQOL for Use in Patients with Osteoarthritis in Spain. Clin Rheumatol 2017, 36, 1855–1864. [Google Scholar] [CrossRef] [PubMed]
- Collins, N.J.; Prinsen, C. a. C.; Christensen, R.; Bartels, E.M.; Terwee, C.B.; Roos, E.M. Knee Injury and Osteoarthritis Outcome Score (KOOS): Systematic Review and Meta-Analysis of Measurement Properties. Osteoarthritis Cartilage 2016, 24, 1317–1329. [Google Scholar] [CrossRef] [PubMed]
- Braaksma, C.; Wolterbeek, N.; Veen, M.R.; Prinsen, C. a. C.; Ostelo, R.W.J.G. Systematic Review and Meta-Analysis of Measurement Properties of the Hip Disability and Osteoarthritis Outcome Score - Physical Function Shortform (HOOS-PS) and the Knee Injury and Osteoarthritis Outcome Score - Physical Function Shortform (KOOS-PS). Osteoarthritis Cartilage 2020, 28, 1525–1538. [Google Scholar] [CrossRef]
- Rat, A.-C.; Coste, J.; Pouchot, J.; Baumann, M.; Spitz, E.; Retel-Rude, N.; Le Quintrec, J.-S.; Dumont-Fischer, D.; Guillemin, F. OAKHQOL: A New Instrument to Measure Quality of Life in Knee and Hip Osteoarthritis. J Clin Epidemiol 2005, 58, 47–55. [Google Scholar] [CrossRef]
- Conner-Spady, B.L.; Marshall, D.A.; Bohm, E.; Dunbar, M.J.; Loucks, L.; Al Khudairy, A.; Noseworthy, T.W. Reliability and Validity of the EQ-5D-5L Compared to the EQ-5D-3L in Patients with Osteoarthritis Referred for Hip and Knee Replacement. Qual Life Res 2015, 24, 1775–1784. [Google Scholar] [CrossRef]
- Bilbao, A.; García-Pérez, L.; Arenaza, J.C.; García, I.; Ariza-Cardiel, G.; Trujillo-Martín, E.; Forjaz, M.J.; Martín-Fernández, J. Psychometric Properties of the EQ-5D-5L in Patients with Hip or Knee Osteoarthritis: Reliability, Validity and Responsiveness. Qual Life Res 2018, 27, 2897–2908. [Google Scholar] [CrossRef] [PubMed]
Table 1.
Sociodemographic and self-reported clinical characteristics of the study sample (n = 266) and test-retest subsample (n = 36).
Table 1.
Sociodemographic and self-reported clinical characteristics of the study sample (n = 266) and test-retest subsample (n = 36).
| Sociodemographic Characteristics |
n (%) or Mean (SD) |
|
Clinical Characteristics |
n (%) |
| Study |
Test-Retest |
|
Study |
Test-Retest |
| Age, years (mean, SD) |
71.9 (10.3) |
72.6 (10.0) |
|
Duration of OA symptoms |
|
|
| Age group |
|
|
|
< 1 year |
27 (10.3) |
1 (2.8) |
| < 60 years |
35 (13.2) |
5 (13.9) |
|
1–5 years |
45 (17.2) |
6 (16.7) |
| 60–69 years |
74 (27.8) |
10 (27.8) |
|
6–10 years |
52 (19.8) |
6 (16.7) |
| 70–79 years |
93 (35.0) |
12 (33.3) |
|
11–15 years |
59 (22.5) |
7 (19.4) |
| ≥ 80 years |
64 (24.1) |
9 (25.0) |
|
16–20 years |
28 (10.7) |
6 (16.7) |
| Sex |
|
|
|
> 20 years |
22 (8.4) |
4 (11.1) |
| Female |
156 (58.6) |
23 (63.9) |
|
Pain frequency |
|
|
| Male |
103 (38.7) |
12 (33.3) |
|
Daily |
143 (53.6) |
15 (42.9)2 |
| Other / missing |
7 (2.7) |
1 (2.8) |
|
Weekly |
50 (18.8) |
9 (25.7) |
| Mother tongue |
|
|
|
Rarely |
59 (22.2) |
9 (25.7) |
| German |
163 (61.3) |
21 (58.3) |
|
Never |
14 (5.4) |
(5.7) |
| Italian |
86 (32.3) |
11 (30.6) |
|
Activity limitation in daily life |
|
|
| Ladin |
6 (2.3) |
2 (5.6) |
|
None |
41 (15.5) |
4 (11.1) |
| Other |
11 (4.1) |
2 (5.6) |
|
Mild |
97 (36.6) |
12 (33.3) |
| Education |
|
|
|
Moderate |
102 (38.5) |
15 (41.7) |
| Compulsory school |
144 (54.1) |
13 (36.1) |
|
Severe |
25 (9.4) |
5 (13.9) |
| Vocational training |
61 (22.9) |
4 (11.1) |
|
Joints affected 1
|
|
|
| Highschool |
43 (16.2) |
16 (44.4) |
|
Left hip |
60 (21.4) |
7 (19.4) |
| University |
18 (6.8) |
3 (8.3) |
|
Right hip |
74 (26.4) |
11 (30.6) |
| Employment status |
|
|
|
Left knee |
96 (34.3) |
15 (41.7) |
| Retired |
186 (69.9) |
24 (66.7) |
|
Right knee |
134 (47.9) |
19 (52.8) |
| Full-time |
39 (14.7) |
6 (16.7) |
|
Prior joint replacement surgery 2
|
71 (26.7)* |
26 (96.3) |
| Part-time |
25 (9.4) |
3 (8.3) |
|
≥ 1 comorbidity 3
|
164 (61.5) |
21 (60.0) |
| Unemployed / Other |
4 (1.5) |
3 (8.3) |
|
Physiotherapy (ever) |
119 (45.1) |
17 (47.2) |
| Subjective economic status |
|
|
|
Any lifestyle change vs. none 4
|
141 (53.0) |
14 (38.8) |
| Very good |
12 (4.5) |
2 (5.6) |
|
Imaging (X-ray/MRI performed) |
201 (75.5) |
30 (83.3) |
| Good |
82 (30.8) |
8 (22.2) |
|
|
|
|
| Moderate |
140 (52.6) |
25 (69.4) |
|
|
|
|
| Poor |
30 (11.3) |
1 (2.8) |
|
|
|
|
| Very poor |
2 (0.8) |
0 |
|
|
|
|
Table 2.
Item-level achievement of the 17 Osteoarthritis Quality Indicators (n = 266).
Table 2.
Item-level achievement of the 17 Osteoarthritis Quality Indicators (n = 266).
| Item |
Osteoarthritis Quality Indicators |
Valid n
|
Yes, n (%) |
| 1 |
Information about OA |
259 |
172 (66.4) |
| 2 |
Information about treatment options |
261 |
177 (67.8) |
| 3 |
Counseling on coping with OA in daily life |
262 |
160 (61.1) |
| 4 |
Advice on physical activity |
257 |
210 (81.6) |
| 5 |
Instruction in physical exercises |
261 |
163 (62.5) |
| 6 |
Advice on weight reduction (if overweight) |
206 |
75 (36.4) |
| 7 |
Support with weight reduction (if overweight) |
179 |
60 (33.5) |
| 8 |
Assessment of joint pain |
254 |
196 (77.2) |
| 9 |
Assessment of daily activity limitations |
256 |
164 (64.1) |
| 10 |
Assessment of need for walking aids |
187 |
58 (31.0) |
| 11 |
Discussion of occupational aspects |
187 |
34 (18.2) |
| 12 |
Follow-up/control visits |
259 |
159 (61.4) |
| 13 |
Prescription of NSAIDs |
234 |
188 (80.3) |
| 14 |
Information about NSAID side effects |
214 |
118 (55.1) |
| 15 |
Corticosteroid injection offered |
216 |
129 (59.7) |
| 16 |
Information about corticosteroid side effects |
182 |
100 (54.9) |
| 17 |
Information/referral for joint replacement |
239 |
152 (63.6) |
Table 3.
Test-retest reliability over a 2-week period for single items in the OA-QI v3-D or OA-QI v3-I questionnaire (n = 36).
Table 3.
Test-retest reliability over a 2-week period for single items in the OA-QI v3-D or OA-QI v3-I questionnaire (n = 36).
| Item |
Quality Indicator Items |
Kappa* |
95% CI†
|
Agreement (%)§
|
| 1 |
Have you been offered information about osteoarthritis? |
0.509 |
0.25–0.77 |
75.0 |
| 2 |
Have you been offered information about treatment options for your osteoarthritis? |
0.525 |
0.23–0.82 |
80.6 |
| 3 |
Have you been offered information about how you can manage your osteoarthritis? |
0.640 |
0.39–0.89 |
83.3 |
| 4 |
Have you been advised that exercise and physical activity are important to help your osteoarthritis? |
0.579 |
0.25–0.91 |
86.1 |
| 5 |
Have you been offered guidance on how you can exercise your joints and be physically active? |
0.497 |
0.21–0.78 |
75.0 |
| 6 |
If you are overweight, have you been advised to try losing weight? |
0.460 |
0.23–0.69 |
63.9 |
| 7 |
Have you been offered or given help to lose weight? |
0.382 |
0.14–0.63 |
61.1 |
| 8 |
Has a health professional discussed with you any problems you may have with daily activities due to your osteoarthritis? |
0.344 |
0.05–0.64 |
72.2 |
| 9 |
If you have trouble walking, has someone discussed with you if a walking aid like walking sticks, cane, or crutch might be helpful? |
0.496 |
0.23–0.75 |
72.2 |
| 10 |
If you have trouble working due to your osteoarthritis, have you been offered advice about how to remain in or return to paid or unpaid work? |
0.692 |
0.49–0.89 |
80.6 |
| 11 |
Has a health professional asked you about your joint pain? |
0.328 |
0.07–0.59 |
61.1 |
| 12 |
Has a health professional discussed with you when you should return for another consultation for your osteoarthritis? |
0.418 |
0.16–0.68 |
66.7 |
| 13 |
Were non-steroidal anti-inflammatory medications the first medication that was recommended to you? (e.g. ibuprofen, diclofenac, naproxen, celecoxib) |
0.397 |
0.10–0.70 |
75.0 |
| 14 |
If you use non-steroidal anti-inflammatory medication, have you received information about possible side effects? |
0.435 |
0.18–0.69 |
66.7 |
| 15 |
If you are severely troubled by pain and other approaches do not help or are unsuitable, have you been offered a steroid injection? |
0.464 |
0.23–0.70 |
66.7 |
| 16 |
If you were offered a steroid injection, were you offered information about possible side effects? |
0.421 |
0.19–0.65 |
61.1 |
| 17 |
If you are severely troubled by your osteoarthritis and exercise, medication, or other approaches do not help, have you been offered a referral for an assessment for surgery? (e.g. joint replacement) |
0.553 |
0.31–0.80 |
74.3 1
|
Table 4.
Bivariate correlations between OA-QI achievement and patient characteristics.
Table 4.
Bivariate correlations between OA-QI achievement and patient characteristics.
| Variable 1
|
Correlation (ρ or r) 2
|
p-value |
Direction |
Effect size 3
|
| Age (years) |
–0.05 |
0.37 |
n.s. |
Negligible |
| Sex (female) |
0.02 |
0.68 |
n.s. |
Negligible |
| Language (Italian) |
0.13 |
0.03 |
↑ |
Small |
| Language (Ladin/other) |
–0.07 |
0.24 |
n.s. |
Negligible |
| Education – vocational |
–0.24 |
<0.01 |
↓ |
Small–moderate |
| Education – university |
–0.15 |
0.02 |
↓ |
Small |
| Employment – full-time |
–0.13 |
0.04 |
↓ |
Small |
| Economic status (worse) |
–0.12 to –0.18 |
0.003–0.05 |
↓ |
Small |
| ≥1 chronic disease |
–0.13 |
0.045 |
↓ |
Small |
| Prior surgery |
0.01 |
0.84 |
n.s. |
Negligible |
| Number of affected joints |
–0.06 |
0.31 |
n.s. |
Negligible |
| Pain frequency |
0.03 |
0.57 |
n.s. |
Negligible |
| Activity limitation |
–0.04 |
0.42 |
n.s. |
Negligible |
| Duration of symptoms |
–0.02 |
0.73 |
n.s. |
Negligible |
| Number of information sources |
0.34 |
<0.001 |
↑ |
Moderate |
| Information use (categorical) |
0.32 |
<0.001 |
↑ |
Moderate |
Table 5.
Mixed-effects linear regression of OA-QI achievement scores, including patient- and practice-level predictors (random intercepts for general practitioners).
Table 5.
Mixed-effects linear regression of OA-QI achievement scores, including patient- and practice-level predictors (random intercepts for general practitioners).
| Predictor * |
β (95% CI) |
p-value |
| Female sex |
–6.18 (–11.62, –0.74) |
0.026 |
| Education (per higher category) |
+2.65 (0.81, 4.49) |
0.005 |
| Activity limitation (per severity level) |
–3.71 (–6.19, –1.23) |
0.004 |
| Age (years) |
–0.01 (–0.13, 0.11) |
0.845 |
| Economic status (per category worse) |
–0.91 (–2.08, 0.26) |
0.129 |
| Comorbidity (≥1 vs. none) |
–2.07 (–6.84, 2.71) |
0.395 |
| Prior joint surgery (yes vs. no) |
–0.12 (–5.36, 5.12) |
0.964 |
| Number of joints affected |
–0.38 (–2.30, 1.55) |
0.701 |
| Pain frequency (per severity level) |
–0.21 (–1.81, 1.39) |
0.794 |
| Duration of symptoms (years) |
–0.06 (–0.87, 0.75) |
0.892 |
| Language: Italian vs. German |
+0.54 (–4.27, 5.34) |
0.823 |
| Language: Ladin vs. German |
–1.79 (–13.18, 9.61) |
0.755 |
| Language: Other vs. German |
+4.62 (–7.41, 16.64) |
0.448 |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).